Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Aim Immunotech Inc (AIM)

Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering GlobeNewswire - Fri Feb 27, 8:00AM CST

OCALA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...

AIM : 0.9076 (-8.32%)
AIM ImmunoTech Announces Extension of Subscription Period of its Previously Announced Rights Offering to March 3, 2026 GlobeNewswire - Wed Feb 25, 8:00AM CST

OCALA, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...

AIM : 0.9076 (-8.32%)
The State Fair of Texas Extends Partnership with accesso® Through 2030, Embracing Innovation and Guest Convenience PR Newswire - Tue Feb 24, 7:00AM CST

ORLANDO, Fla. , Feb. 24, 2026 /CNW/ --  accesso Technology Group  (AIM: ACSO), the leading technology partner to the leisure and entertainment industry, today announced the renewal...

AIM : 0.9076 (-8.32%)
The State Fair of Texas Extends Partnership with accesso® Through 2030, Embracing Innovation and Guest Convenience PR Newswire - Tue Feb 24, 7:00AM CST

ORLANDO, Fla. , Feb. 24, 2026 /PRNewswire/ --  accesso Technology Group  (AIM: ACSO), the leading technology partner to the leisure and entertainment industry, today announced the renewal...

AIM : 0.9076 (-8.32%)
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca’s Durvalumab in the Treatment of Metastatic Pancreatic Cancer GlobeNewswire - Mon Feb 23, 7:55AM CST

OCALA, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM)  (“AIM” or the “Company”) today announced milestones in the expected timeline for the ongoing Phase...

AIM : 0.9076 (-8.32%)
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering GlobeNewswire - Thu Feb 12, 3:35PM CST

This press release is issued solely to correct a date from an AIM press release dated February 11, 2026. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on February...

AIM : 0.9076 (-8.32%)
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event GlobeNewswire - Thu Feb 12, 7:55AM CST

Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Thursday, February 19th at 4:00 PM ET Event to focus on lead program, Ampligen, for treatment of pancreatic...

AIM : 0.9076 (-8.32%)
AIM ImmunoTech Announces Commencement of Rights Offering GlobeNewswire - Wed Feb 11, 7:30AM CST

OCALA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...

AIM : 0.9076 (-8.32%)
accesso® and Adyen Expand Strategic Partnership to Enhance Platform Payments Capabilities at Global Scale PR Newswire - Tue Feb 10, 2:00AM CST

ORLANDO, Fla. , Feb. 10, 2026 /PRNewswire/ --  accesso Technology Group  (AIM: ACSO), the premier technology solutions provider to leisure, entertainment, and cultural markets,...

AIM : 0.9076 (-8.32%)
accesso® and Adyen Expand Strategic Partnership to Enhance Platform Payments Capabilities at Global Scale PR Newswire - Tue Feb 10, 2:00AM CST

ORLANDO, Fla. , Feb. 10, 2026 /CNW/ --  accesso Technology Group  (AIM: ACSO), the premier technology solutions provider to leisure, entertainment, and cultural markets,...

AIM : 0.9076 (-8.32%)

Barchart Exclusives

Why 1 Analyst Thinks DocuSign Stock Can Gain Over 170% in 2026 Barchart - 5 minutes ago
Even after a steep pullback, DocuSign could surge over 170% if it hits the $124 Street-high target set by Citizens, indicating a bold turnaround call. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot